Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Factors identified leading to hospital discharges against physician’s advice

Leaving the hospital against the advice of physicians is a rising trend with negative consequences. In an effort to understand why patients chose to leave hospital care early, researchers have published findings in the Journal of the American Geriatrics Society to assist in further research and provide answers on how healthcare providers can stop this trend.

How insurers could have gamed ACA risk adjustment

Oregon-based provider and insurer Zoom is being investigated for allegations it tampered with medical claims to make sure it didn’t have to pay into the risk adjustment pool for the Affordable Care Act (ACA) marketplaces.

Cigna’s reentry into Medicare Advantage could be precursor to Humana deal

CMS has lifted Medicare Advantage (MA) sanctions on Cigna, allowing the insurer to market both MA and Medicare Part D prescription drug plans with effective dates beginning July 1.

Thumbnail

Nevada ‘Medicaid for all’ bill vetoed

Nevada Gov. Brian Sandoval has vetoed legislation to create a Medicaid buy-in option in the state.

Controlling type 1 diabetes could be as easy as sending a text, literally

Patients living with type 1 diabetes are constantly tinkering with glucose monitors and insulin pumps but all Dana Lewis, a health communications professional, has to do is text her pancreas. The “pancreas” combines an insulin pump and glucose monitor and connects to her smartphone to cut the hundreds of interactions conventional type 1 diabetes requires to just six a day.

Web-based calculator accurately predicts cancer survival

Predicting a cancer patient's chance of survival allows individuals to make informed decisions, but many techniques are not especially accurate. In a study, published in BMJ, researchers tested a new web-based survival calculator in patients with bowel cancer.

Senate Republicans struggle to explain how AHCA would benefit consumers

Eight Republicans in the Senate were asked by Vox to explain what problems in the healthcare system the American Health Care Act (AHCA) is trying to solve and how it will be better than the Affordable Care Act—and while some could explain desired outcomes from the bill, identifying the exact policies to achieve those goals seemed to be difficult.

Screening tool IDs patients at risk for malnutrition

Malnutrition in surgical patients raises mortality rates, readmissions and poor outcomes while also reducing recovery time and quality of life. Researchers at Johns Hopkins Hospital (JHH) in Baltimore have published a study in The Annals of Thoracic Surgery evaluating a new screening tool capable of identifying patients at risk for malnutrition.

Displaying 4529 - 4536 of 6647

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup